Pub. Date : 2020 Feb
PMID : 31608549
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Basal insulin secretion capacity predicts the initial response and maximum levels of beta-hydroxybutyrate during therapy with the SGLT2 inhibitor, tofogliflozin, in relation to weight loss. | 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol | insulin | Homo sapiens |
| 2 | CONCLUSIONS: Lower basal insulin secretion capacity might predict greater initial BHB elevations and max-BHB levels during long-term tofogliflozin therapy. | 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol | insulin | Homo sapiens |